Evaluation of local guideline introduction on surgical antimicrobial prophylaxis prescribing for open reduction internal fixations at an Australian tertiary hospital

IF 1 Q4 PHARMACOLOGY & PHARMACY
Sarah Hassan BPharm (Hons), PhD, Vincent Chan BSc (Hons), BPharm, MPH, PhD, GradCertAcadPrac, AACPA, Julie E. Stevens BSc, BPharm (Hons), PhD, Ieva Stupans BPharm (Hons), PhD, Juliette Gentle MBBS, FRACS (Orth)
{"title":"Evaluation of local guideline introduction on surgical antimicrobial prophylaxis prescribing for open reduction internal fixations at an Australian tertiary hospital","authors":"Sarah Hassan BPharm (Hons), PhD,&nbsp;Vincent Chan BSc (Hons), BPharm, MPH, PhD, GradCertAcadPrac, AACPA,&nbsp;Julie E. Stevens BSc, BPharm (Hons), PhD,&nbsp;Ieva Stupans BPharm (Hons), PhD,&nbsp;Juliette Gentle MBBS, FRACS (Orth)","doi":"10.1002/jppr.1886","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Guidelines advocate for the use of single-dose prophylaxis in open reduction internal fixation (ORIF) procedures. The presence of local (institutional) guidelines may assist in the uptake of evidence-based recommendations.</p>\n </section>\n \n <section>\n \n <h3> Aim</h3>\n \n <p>To determine the impact of local guideline introduction on prescribing practice for ORIF procedures at a metropolitan hospital in relation to our previous audit investigating adherence to national guidelines, which found that only 20.4% of ORIF patients received single-dose prophylaxis.</p>\n </section>\n \n <section>\n \n <h3> Method</h3>\n \n <p>Antibiotic prescribing was audited for patients undergoing ORIF of closed fractures from July–December 2021 at a metropolitan, tertiary hospital following guideline introduction in April 2021. Data on perioperative prescribing regimens were collected, with results compared to recommendations in local guidelines. Descriptive statistics, chi-squared test, and Fisher's exact test were used to report categorical variables. Ethics approval was granted by Northern Health Office of Research, Ethics, and Governance (Reference no: NLR 72459) and registered with the RMIT University College Human Ethics Advisory Network (Reference no: RM 24642).</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Data were collected for 165 patients. Almost all patients (93.5%) received cefazolin preoperatively as per guidelines. Only 22.6% of patients received single-dose prophylaxis as per local guideline recommendations, with overall adherence to guidelines only 16.4%.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Little change was observed in the proportion of patients who received single-dose prophylaxis as compared to our previous audit. There is a need to understand why guidelines are not adhered to despite the availability of national and local guidelines. An evaluation of local barriers may assist with informing future implementation strategies.</p>\n </section>\n </div>","PeriodicalId":16795,"journal":{"name":"Journal of Pharmacy Practice and Research","volume":"54 1","pages":"33-40"},"PeriodicalIF":1.0000,"publicationDate":"2023-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jppr.1886","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmacy Practice and Research","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jppr.1886","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Guidelines advocate for the use of single-dose prophylaxis in open reduction internal fixation (ORIF) procedures. The presence of local (institutional) guidelines may assist in the uptake of evidence-based recommendations.

Aim

To determine the impact of local guideline introduction on prescribing practice for ORIF procedures at a metropolitan hospital in relation to our previous audit investigating adherence to national guidelines, which found that only 20.4% of ORIF patients received single-dose prophylaxis.

Method

Antibiotic prescribing was audited for patients undergoing ORIF of closed fractures from July–December 2021 at a metropolitan, tertiary hospital following guideline introduction in April 2021. Data on perioperative prescribing regimens were collected, with results compared to recommendations in local guidelines. Descriptive statistics, chi-squared test, and Fisher's exact test were used to report categorical variables. Ethics approval was granted by Northern Health Office of Research, Ethics, and Governance (Reference no: NLR 72459) and registered with the RMIT University College Human Ethics Advisory Network (Reference no: RM 24642).

Results

Data were collected for 165 patients. Almost all patients (93.5%) received cefazolin preoperatively as per guidelines. Only 22.6% of patients received single-dose prophylaxis as per local guideline recommendations, with overall adherence to guidelines only 16.4%.

Conclusion

Little change was observed in the proportion of patients who received single-dose prophylaxis as compared to our previous audit. There is a need to understand why guidelines are not adhered to despite the availability of national and local guidelines. An evaluation of local barriers may assist with informing future implementation strategies.

对澳大利亚一家三级医院引入开刀复位内固定手术抗菌药预防处方地方指南的评估
背景指南提倡在开放复位内固定术(ORIF)中使用单剂量预防疗法。地方(机构)指南的存在可能有助于采纳循证建议。 目的 针对我们之前对国家指南遵守情况的审计发现,仅有 20.4% 的 ORIF 患者接受了单剂量预防治疗,从而确定地方指南的引入对一家都市医院 ORIF 手术处方实践的影响。 方法 在 2021 年 4 月引入指南后,我们于 2021 年 7 月至 12 月对一家大都市三级医院接受闭合性骨折 ORIF 手术的患者的抗生素处方进行了审核。收集了围手术期处方方案的数据,并将结果与当地指南的建议进行了比较。描述性统计、卡方检验和费雪精确检验用于报告分类变量。该研究获得了北部卫生部研究、伦理和管理办公室的伦理批准(编号:NLR 72459),并在皇家墨尔本理工大学学院人类伦理咨询网络注册(编号:RM 24642)。 结果 收集了 165 名患者的数据。几乎所有患者(93.5%)都按照指南在术前接受了头孢唑啉治疗。只有 22.6% 的患者按照当地指南的建议接受了单剂量预防治疗,而遵守指南的总体比例仅为 16.4%。 结论 与我们之前的审计相比,接受单剂量预防的患者比例变化不大。我们有必要了解,尽管有国家和地方指南,但为何仍有人不遵守指南。对当地存在的障碍进行评估有助于为未来的实施策略提供依据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Pharmacy Practice and Research
Journal of Pharmacy Practice and Research Health Professions-Pharmacy
CiteScore
1.60
自引率
9.50%
发文量
68
期刊介绍: The purpose of this document is to describe the structure, function and operations of the Journal of Pharmacy Practice and Research, the official journal of the Society of Hospital Pharmacists of Australia (SHPA). It is owned, published by and copyrighted to SHPA. However, the Journal is to some extent unique within SHPA in that it ‘…has complete editorial freedom in terms of content and is not under the direction of the Society or its Council in such matters…’. This statement, originally based on a Role Statement for the Editor-in-Chief 1993, is also based on the definition of ‘editorial independence’ from the World Association of Medical Editors and adopted by the International Committee of Medical Journal Editors.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信